Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29146401

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Dec
First author
Martin M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Dec;18(12):1568-1569. doi: 10.1016/S1470-2045(17)30844-6.
    note
    Source null
    related pmid
    29146400
    relationship
    Comment in

Authors and identifiers

  1. name
    Martin M
    type
    Author
  2. name
    Holmes FA
    type
    Author
  3. name
    Ejlertsen B
    type
    Author
  4. name
    Delaloge S
    type
    Author
  5. name
    Moy B
    type
    Author
  6. name
    Iwata H
    type
    Author
  7. name
    von Minckwitz G
    type
    Author
  8. name
    Chia SKL
    type
    Author
  9. name
    Mansi J
    type
    Author
  10. name
    Barrios CH
    type
    Author
  11. name
    Gnant M
    type
    Author
  12. name
    Tomašević Z
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Martin M
    type
    Author
  2. name
    Holmes FA
    type
    Author
  3. name
    Ejlertsen B
    type
    Author
  4. name
    Delaloge S
    type
    Author
  5. name
    Moy B
    type
    Author
  6. name
    Iwata H
    type
    Author
  7. name
    von Minckwitz G
    type
    Author
  8. name
    Chia SKL
    type
    Author
  9. name
    Mansi J
    type
    Author
  10. name
    Barrios CH
    type
    Author
  11. name
    Gnant M
    type
    Author
  12. name
    Tomašević Z
    type
    Author
bibliography ids
  1. nci-bib-620aa9ea8a03b00790b906a1
book metadata
content sha256
231ecadbbcb1ef4a4ecfa48255657842e7fceab7d9114c6d031c3822c2e5c5d7
document type
citation
dois
  1. 10.1016/S1470-2045(17)30717-9
electronic publication date
display
2017 Nov 13
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29146401
immutable id
pubmed:29146401@231ecadbbcb1ef4a4ecfa48255657842e7fceab7d9114c6d031c3822c2e5c5d7
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
12
name
The Lancet. Oncology
nlm unique id
100957246
pages
1688-1700
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Dec;18(12):1568-1569. doi: 10.1016/S1470-2045(17)30844-6.
    note
    Source null
    related pmid
    29146400
    relationship
    Comment in
outcomes validated
false
pmid
29146401
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
8522ff7a6dfbae3e9642c6ec1c6ba1230b7edd44c70396d84fe9e2bcb044a818
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29146401/
title
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice